9.28 USD
+0.03 (+0.32%)
Taking everything into account, INFU scores 6 out of 10 in our fundamental rating. INFU was compared to 101 industry peers in the Health Care Providers & Services industry. INFU scores excellent points on both the profitability and health parts. This is a solid base for a good stock. INFU has a correct valuation and a medium growth rate. With these ratings, INFU could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year INFU was profitable.
INFU had a positive operating cash flow in the past year.
INFU had positive earnings in each of the past 5 years.
In the past 5 years INFU always reported a positive cash flow from operatings.
1.2 Ratios
INFU has a better Return On Assets (5.03%) than 78.22% of its industry peers.
With a decent Return On Equity value of 9.30%, INFU is doing good in the industry, outperforming 70.30% of the companies in the same industry.
With a decent Return On Invested Capital value of 9.55%, INFU is doing good in the industry, outperforming 79.21% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for INFU is significantly below the industry average of 9.27%.
The last Return On Invested Capital (9.55%) for INFU is above the 3 year average (3.86%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.03% | ||
| ROE | 9.3% | ||
| ROIC | 9.55% |
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
1.3 Margins
The Profit Margin of INFU (3.63%) is better than 71.29% of its industry peers.
INFU's Profit Margin has been stable in the last couple of years.
With a decent Operating Margin value of 7.35%, INFU is doing good in the industry, outperforming 71.29% of the companies in the same industry.
INFU's Operating Margin has improved in the last couple of years.
INFU has a Gross Margin of 54.55%. This is in the better half of the industry: INFU outperforms 77.23% of its industry peers.
In the last couple of years the Gross Margin of INFU has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.35% | ||
| PM (TTM) | 3.63% | ||
| GM | 54.55% |
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so INFU is still creating some value.
Compared to 1 year ago, INFU has more shares outstanding
Compared to 5 years ago, INFU has more shares outstanding
INFU has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.54 indicates that INFU is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.54, INFU is in the better half of the industry, outperforming 73.27% of the companies in the same industry.
INFU has a debt to FCF ratio of 1.97. This is a very positive value and a sign of high solvency as it would only need 1.97 years to pay back of all of its debts.
INFU has a Debt to FCF ratio of 1.97. This is amongst the best in the industry. INFU outperforms 83.17% of its industry peers.
INFU has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of INFU (0.48) is better than 63.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 1.97 | ||
| Altman-Z | 3.54 |
ROIC/WACC1.08
WACC8.81%
2.3 Liquidity
A Current Ratio of 2.19 indicates that INFU has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.19, INFU belongs to the best of the industry, outperforming 81.19% of the companies in the same industry.
A Quick Ratio of 1.84 indicates that INFU should not have too much problems paying its short term obligations.
The Quick ratio of INFU (1.84) is better than 76.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.19 | ||
| Quick Ratio | 1.84 |
3. Growth
3.1 Past
INFU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 333.33%, which is quite impressive.
Measured over the past years, INFU shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.59% on average per year.
INFU shows a small growth in Revenue. In the last year, the Revenue has grown by 7.22%.
Measured over the past years, INFU shows a quite strong growth in Revenue. The Revenue has been growing by 10.70% on average per year.
EPS 1Y (TTM)333.33%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%37.5%
Revenue 1Y (TTM)7.22%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%3.31%
3.2 Future
Based on estimates for the next years, INFU will show a very strong growth in Earnings Per Share. The EPS will grow by 68.50% on average per year.
The Revenue is expected to grow by 7.69% on average over the next years.
EPS Next Y165.2%
EPS Next 2Y97.7%
EPS Next 3Y68.5%
EPS Next 5YN/A
Revenue Next Year6.04%
Revenue Next 2Y6.38%
Revenue Next 3Y7.69%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
INFU is valuated quite expensively with a Price/Earnings ratio of 35.69.
INFU's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.15. INFU is valued slightly more expensive when compared to this.
The Price/Forward Earnings ratio is 23.74, which indicates a rather expensive current valuation of INFU.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INFU is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of INFU to the average of the S&P500 Index (36.12), we can say INFU is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.69 | ||
| Fwd PE | 23.74 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INFU indicates a somewhat cheap valuation: INFU is cheaper than 76.24% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, INFU is valued a bit cheaper than 78.22% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.17 | ||
| EV/EBITDA | 9.13 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INFU has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as INFU's earnings are expected to grow with 68.50% in the coming years.
PEG (NY)0.22
PEG (5Y)3.37
EPS Next 2Y97.7%
EPS Next 3Y68.5%
5. Dividend
5.1 Amount
No dividends for INFU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSEARCA:INFU (11/28/2025, 3:40:00 PM)
9.28
+0.03 (+0.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners75.26%
Inst Owner Change-2.42%
Ins Owners4.59%
Ins Owner Change0.36%
Market Cap189.59M
Revenue(TTM)134.86M
Net Income(TTM)5.07M
Analysts83.64
Price Target14.48 (56.03%)
Short Float %0.81%
Short Ratio0.7
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)151.14%
Min EPS beat(2)75.49%
Max EPS beat(2)226.8%
EPS beat(4)3
Avg EPS beat(4)69.56%
Min EPS beat(4)-48.06%
Max EPS beat(4)226.8%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.63%
Min Revenue beat(2)-2.26%
Max Revenue beat(2)0.99%
Revenue beat(4)2
Avg Revenue beat(4)-1.44%
Min Revenue beat(4)-4.92%
Max Revenue beat(4)0.99%
Revenue beat(8)4
Avg Revenue beat(8)-0.36%
Revenue beat(12)6
Avg Revenue beat(12)-0.46%
Revenue beat(16)7
Avg Revenue beat(16)-1.59%
PT rev (1m)3.27%
PT rev (3m)13.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)1.96%
EPS NY rev (3m)1.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.69 | ||
| Fwd PE | 23.74 | ||
| P/S | 1.36 | ||
| P/FCF | 14.17 | ||
| P/OCF | 7.14 | ||
| P/B | 3.48 | ||
| P/tB | 4.34 | ||
| EV/EBITDA | 9.13 |
EPS(TTM)0.26
EY2.8%
EPS(NY)0.39
Fwd EY4.21%
FCF(TTM)0.66
FCFY7.06%
OCF(TTM)1.3
OCFY14.01%
SpS6.85
BVpS2.67
TBVpS2.14
PEG (NY)0.22
PEG (5Y)3.37
Graham Number3.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.03% | ||
| ROE | 9.3% | ||
| ROCE | 12.09% | ||
| ROIC | 9.55% | ||
| ROICexc | 9.63% | ||
| ROICexgc | 11.06% | ||
| OM | 7.35% | ||
| PM (TTM) | 3.63% | ||
| GM | 54.55% | ||
| FCFM | 9.57% |
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
ROICexc(3y)3.88%
ROICexc(5y)5.02%
ROICexgc(3y)4.43%
ROICexgc(5y)5.92%
ROCE(3y)4.88%
ROCE(5y)5.98%
ROICexgc growth 3Y31.39%
ROICexgc growth 5Y0.4%
ROICexc growth 3Y34.21%
ROICexc growth 5Y4.6%
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
F-Score9
Asset Turnover1.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 1.97 | ||
| Debt/EBITDA | 1.12 | ||
| Cap/Depr | 99.64% | ||
| Cap/Sales | 9.42% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 113.02% | ||
| Profit Quality | 263.84% | ||
| Current Ratio | 2.19 | ||
| Quick Ratio | 1.84 | ||
| Altman-Z | 3.54 |
F-Score9
WACC8.81%
ROIC/WACC1.08
Cap/Depr(3y)114.8%
Cap/Depr(5y)115.78%
Cap/Sales(3y)11.93%
Cap/Sales(5y)13.88%
Profit Quality(3y)4561.75%
Profit Quality(5y)2764.31%
High Growth Momentum
Growth
EPS 1Y (TTM)333.33%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%37.5%
EPS Next Y165.2%
EPS Next 2Y97.7%
EPS Next 3Y68.5%
EPS Next 5YN/A
Revenue 1Y (TTM)7.22%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%3.31%
Revenue Next Year6.04%
Revenue Next 2Y6.38%
Revenue Next 3Y7.69%
Revenue Next 5YN/A
EBIT growth 1Y159.69%
EBIT growth 3Y34.69%
EBIT growth 5Y14.35%
EBIT Next Year309.04%
EBIT Next 3Y71.57%
EBIT Next 5YN/A
FCF growth 1Y355.58%
FCF growth 3Y16.52%
FCF growth 5YN/A
OCF growth 1Y157.31%
OCF growth 3Y3.76%
OCF growth 5Y8.08%
INFUSYSTEM HOLDINGS INC / INFU FAQ
Can you provide the ChartMill fundamental rating for INFUSYSTEM HOLDINGS INC?
ChartMill assigns a fundamental rating of 6 / 10 to INFU.
Can you provide the valuation status for INFUSYSTEM HOLDINGS INC?
ChartMill assigns a valuation rating of 5 / 10 to INFUSYSTEM HOLDINGS INC (INFU). This can be considered as Fairly Valued.
How profitable is INFUSYSTEM HOLDINGS INC (INFU) stock?
INFUSYSTEM HOLDINGS INC (INFU) has a profitability rating of 7 / 10.
What is the financial health of INFUSYSTEM HOLDINGS INC (INFU) stock?
The financial health rating of INFUSYSTEM HOLDINGS INC (INFU) is 7 / 10.
What is the expected EPS growth for INFUSYSTEM HOLDINGS INC (INFU) stock?
The Earnings per Share (EPS) of INFUSYSTEM HOLDINGS INC (INFU) is expected to grow by 165.2% in the next year.